Synergism Between K-Ras(Val12) and Mutant Apc Accelerates Murine Large Intestinal Tumourigenesis

Feijun Luo,George Poulogiannis,Hongtao Ye,Rifat Hamoudi,Mark J. Arends
DOI: https://doi.org/10.3892/or.2011.1288
2011-01-01
Oncology Reports
Abstract:K-ras (KRAS) is mutated in 40-50% of human colorectal adenomas and carcinomas and plays key roles in cell proliferation, apoptosis, motility and differentiation, but its functional contribution to intestinal tumourigenesis in vivo remains incompletely understood. We have previously crossed K-ras(Val12) transgenic mice with Ah-Cre mice to produce K-ras(Val12)/Cre offspring that inducibly express K-ras(Val12) 4A and 4B in the intestines, but this alone showed no significant effect on intestinal adenoma formation. Here, we crossed these mice with Min mice to evaluate the effect of K-ras(Val12) and Apc mutation on intestinal tumourigenesis in vivo. The double mutant K-ras(Val12)/Cre/Apc(Min/+) mice showed a moderate (1.86-fold) increase in adenomas in the small intestines, but a striking acceleration (6-fold increase) of large intestinal adenoma formation (P<0.01) and significantly reduced survival (by similar to 5 weeks) compared with control Apc(Min/+) mice (P<0.01). There was recombination of the mutant K-ras(Val12) transgene in 80% of large intestinal adenomas with expression of both K-ras(Val12) 4A and 4B isoform transcripts and expression of K-Ras(Val12) protein. The large intestinal adenomas showed immunohistochemical evidence of activation of MapK, Akt and Wnt signaling pathways and this was confirmed by quantitative RT-PCR analysis of relative transcript expression levels of target genes using a panel of 23 selected genes evaluated in both adenomas and non-tumour-bearing intestines. Several genes including Tiam1, Gastrin, CD44, uPA, Igfbp4, VEGF and Cox-2 that are known to be transcriptionally regulated by activation of the Wnt signaling pathway were found to be expressed at higher levels in the large intestinal adenomas from K-ras(Val12)/Cre/Apc(Min/+) compared with those from controls, although other Wnt signaling pathway target genes remained unchanged. These data show that intestinal expression of K-ras(Val12) accelerates Apc-initiated intestinal adenomagenesis in vivo with particularly striking tumour promotion in the large intestines and indicate synergistic effects between mutant K-ras and mutant Apc in this process.
What problem does this paper attempt to address?